H T cell tolerance inside a double-blind, placebo-controlled, pilot section II

H T cell tolerance inside a double-blind, placebo-controlled, pilot phase II trial. Arthritis Rheum 2009, sixty:3207-3216. Kavanaugh A, Genovese M, Baughman J, Kivitz A, Bulpitt K, Olsen N, Weisman M, Matteson E, Furst D, van Vollenhoven R, Anderson J, Cohen S, Wei N, Meijerink J, Jacobs C, Mocci S: Allele and antigen-specific cure of rheumatoid arthritis: a double blind, placebo controlled section one trial. J Rheumatol 2003, thirty:449-454. Staines NA, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/11011031 Derry CJ, Marinova-Mutafchieva L, Ali N, Davies DH, Murphy JJ: Constraints within the efficacy of mucosal tolerance in treatment of human and animal arthritic diseases. Ann Ny Acad Sci 2004, 1029:250-259. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised purpose of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF therapy. J Exp Med 2004, two hundred:277-285. Pettit AR, MacDonald KPA, O’Sullivan B, Thomas R: Differentiated dendritic cells expressing nuclear RelB are predominantly positioned in rheumatoid synovial tissue perivascular mononuclear mobile aggregates. Arthritis Rheum 2000, forty three:791-800. Thomas R, Quinn C: Practical differentiation of dendritic cells in rheumatoid arthritis: role of CD86 RS 09 inside the synovium. J Immunol 1996, 156:3074-3086. Thomas R, Davis LS, Lipsky PE: Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994, 152:2613-2623. Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB: Periodontal ailment as well as the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012, sixty four:3083-3094. Lutzky V, Hannawi S, Thomas R: Cells of your synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther 2007, nine:219. Kenna TJ, Thomas R, Steptoe RJ: Steady-state dendritic cells expressing cognate antigen terminate memory CD8+ T-cell responses. Blood 2008, 111:2091-2100. Zhang ZY, Lee CS, Lider O, Weiner HL: Suppression of adjuvant arthritis in Lewis rats by oral administration of variety II collagen. J Immunol 1990, one hundred forty five:2489-2493.Thomas Arthritis Investigate Treatment 2013, 15:204 http://arthritis-research.com/content/15/1/Page nine of42. Thompson HS, Harper N, Bevan DJ, Staines NA: Suppression of collagen induced arthritis by oral administration of variety II collagen: improvements in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity 1993, 16:189-199. 43. Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, Jung YO, Koh HJ, Do JH, Kim H, Kim HY: Induction of IL-10-producing CD4+CD25+ T cells in animal design of collagen-induced arthritis by oral administration of form II collagen. Arthritis Res Ther 2004, six:R213-R219. forty four. Billingham ME, Carney S, Butler R, Colston MJ: A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but will not be itself arthritogenic. J Exp Med 1990, 171:339-344. forty five. Jorgensen C, Gedon E, Jaquet C, Sany J: Gastric administration of recombinant sixty five kDa heat shock protein delays the severity of variety II collagen induced arthritis in mice. J Rheumatol 1998, 25:763-767. 46. Sieper J, Kary S, Sorensen H, Alten R, Eggens U, Massive W, Hiepe F, Kuhne A, Listing J, Ulbrich N, Braun J, Zink A, Mitchison NA: Oral form II collagen cure in early rheumatoid arthritis. A double-blind, placebocontrolled, randomized trial. Arthritis Rheum 1996, 39:41-51. forty seven. Barnett ML, Kremer JM, St Clair EW, Clegg DO, Furst D, Weisman M, Fletcher MJ,.